Daewoong Co., Ltd. (KRX:003090)

Market Cap	626.77B -29.5%
Revenue (ttm)	2.12T +4.6%
Net Income	179.40B +119.2%
EPS	4,328.21 +116.1%
Shares Out	42.04M
PE Ratio	3.44
Forward PE	n/a
Dividend	200.00 (1.34%)
Ex-Dividend Date	Dec 29, 2025

Volume	71,115
Open	14,530
Previous Close	14,520
Day's Range	14,530 - 15,100
52-Week Range	14,380 - 30,600
Beta	0.28
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 404
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2025, Daewoong's revenue was 2.07 trillion, an increase of 6.79% compared to the previous year's 1.94 trillion. Earnings were 175.06 billion, an increase of 202.43%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 28, 2026

Data Sources Report a data error